These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 1361441)

  • 41. Elevated striatal dopamine levels following administration of D-DOPA and its alpha-keto acid metabolite DHPPA: behavioral and physiological studies in vivo in the rat.
    Brannan T; Prikhojan A; Yahr MD
    Brain Res; 1996 Apr; 718(1-2):165-8. PubMed ID: 8773780
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of postpuberal castration on dopamine receptor sensitivity in the male rat brain.
    Klint T; Hillegaart V; Edlund PO; Wijkström A; Ahlenius S
    Pharmacol Toxicol; 1988 Feb; 62(2):64-8. PubMed ID: 3353353
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Central and peripheral mechanisms contribute to the antiemetic actions of delta-9-tetrahydrocannabinol against 5-hydroxytryptophan-induced emesis.
    Darmani NA; Johnson JC
    Eur J Pharmacol; 2004 Mar; 488(1-3):201-12. PubMed ID: 15044052
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antagonism of AP-5-induced sniffing stereotypy links umespirone to atypical antipsychotics.
    Schmidt WJ; Krähling H; Ruhland M
    Life Sci; 1991; 48(6):499-505. PubMed ID: 1671523
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Improving effects of long-term growth hormone treatment on monoaminergic neurotransmission and related behavioral tests in aged rats.
    Esteban S; Garau C; Aparicio S; Moranta D; Barceló P; Ramis M; Tresguerres JA; Rial R
    Rejuvenation Res; 2010 Dec; 13(6):707-16. PubMed ID: 21208059
    [TBL] [Abstract][Full Text] [Related]  

  • 46. L-type calcium channel blockade on haloperidol-induced c-Fos expression in the striatum.
    Lee J; Rushlow WJ; Rajakumar N
    Neuroscience; 2007 Nov; 149(3):602-16. PubMed ID: 17913375
    [TBL] [Abstract][Full Text] [Related]  

  • 47. High-frequency stimulation of the subthalamic nucleus prolongs the increase in striatal dopamine induced by acute l-3,4-dihydroxyphenylalanine in dopaminergic denervated rats.
    Lacombe E; Carcenac C; Boulet S; Feuerstein C; Bertrand A; Poupard A; Savasta M
    Eur J Neurosci; 2007 Sep; 26(6):1670-80. PubMed ID: 17822436
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Neurochemical and behavioral responses to cocaine in adult male rats with neonatal isolation experience.
    Kosten TA; Zhang XY; Kehoe P
    J Pharmacol Exp Ther; 2005 Aug; 314(2):661-7. PubMed ID: 15845857
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clozapine and cocaine effects on dopamine and serotonin release in nucleus accumbens during psychostimulant behavior and withdrawal.
    Broderick PA; Hope O; Okonji C; Rahni DN; Zhou Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan; 28(1):157-71. PubMed ID: 14687870
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effect of LSD and 2-bromo LSD on the striatal DOPA accumulation after decarboxylase inhibition in rats.
    Persson SA
    Eur J Pharmacol; 1977 May; 43(1):73-83. PubMed ID: 16756
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ziprasidone (CP-88,059): a new antipsychotic with combined dopamine and serotonin receptor antagonist activity.
    Seeger TF; Seymour PA; Schmidt AW; Zorn SH; Schulz DW; Lebel LA; McLean S; Guanowsky V; Howard HR; Lowe JA
    J Pharmacol Exp Ther; 1995 Oct; 275(1):101-13. PubMed ID: 7562537
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Striatal dopamine-mediated motor behavior is altered following occlusion of the middle cerebral artery.
    Borlongan CV; Martinez R; Shytle RD; Freeman TB; Cahill DW; Sanberg PR
    Pharmacol Biochem Behav; 1995 Sep; 52(1):225-9. PubMed ID: 7501669
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Single dose human pharmacology of umespirone.
    Holland RL; Wesnes K; Dietrich B
    Eur J Clin Pharmacol; 1994; 46(5):461-8. PubMed ID: 7957544
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Time and dose influences on the behavioral effects of L-DOPA and 5-hydroxytryptophan after inhibition of extracerebral decarboxylase.
    Gronan RJ
    Pharmacol Biochem Behav; 1975; 3(2):161-6. PubMed ID: 1079949
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Behavioural and biochemical effects of L-dopa after inhibition of dopamine- -hydroxylase in reserpine pretreated rats.
    Ahlenius S; Engel J
    Naunyn Schmiedebergs Arch Pharmakol; 1971; 270(4):349-60. PubMed ID: 4255378
    [No Abstract]   [Full Text] [Related]  

  • 56. Possible explanations for the antagonism by nicotine against reserpine-induced depletion of monoamines in mouse brain.
    Oishi R; Suemaru K; Furuno K; Gomita Y; Saeki K
    Naunyn Schmiedebergs Arch Pharmacol; 1993 Aug; 348(2):154-7. PubMed ID: 8232594
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Biochemical and behavioral effects of l-DOPA methyl ester in cats treated with reserpine.
    Hanson LC; Utley JD
    Psychopharmacologia; 1965 Jul; 8(2):140-4. PubMed ID: 5853737
    [No Abstract]   [Full Text] [Related]  

  • 58. Behavioural and neurochemical interactions between chronic reserpine and chronic antidepressants. A possible model for the detection of atypical antidepressants.
    Jancsár SM; Leonard BE
    Biochem Pharmacol; 1983 May; 32(10):1569-71. PubMed ID: 6134530
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Region-selective activation of brain monoamine synthesis by sexual activity in the male rat.
    Ahlenius S; Carlsson A; Hillegaart V; Hjorth S; Larsson K
    Eur J Pharmacol; 1987 Nov; 144(1):77-82. PubMed ID: 3436362
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Monoamine roles in retention and reversal of delayed response in cats.
    Roberge AG; Boisvert C; Everett J
    Pharmacol Biochem Behav; 1980 Feb; 12(2):229-34. PubMed ID: 6966408
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.